Article
[HBV genotype and liver histology effect of peginterferon alpha treatment of HBeAg-position chronic hepatitis B].
Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology - 1 Jun 2013
Lu Chuan-Tong, Gao Guo-Sheng, Yan Hua-Dong, Hu Yao-Ren
Abstract excerpt
OBJECTIVE: To investigate the efficacy of PEG-interferon alpha (PEG-IFN alpha) treatment of HBeAg-positive chronic hepatitis B and HBV genotypes and liver tissues effect of HBeAg seroconversion. METHODS: 54 cases confirmed by liver biopsy, genotype clear HBeAg positive chronic hepatitis B (CHB) patients according to body weight, respectively, subcutaneous injection of PEG-IFN-alpha2a 135 microg or 180 microg, or...
Topics
- Adult
- Antiviral Agents
- Female
- Genotype
- Hepatitis B e Antigens
- Hepatitis B virus
- Hepatitis B, Chronic
- Humans
- Interferon alpha-2
- Interferon-alpha
- Liver
- Logistic Models
- Male
- Middle Aged
- Polyethylene Glycols
- Recombinant Proteins